Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Asker Healthcare Group AB (ASKER)
Market Closed
12 Jun, 15:25
XSTO
All
(4)
DE
(2)
SE
(1)
GB
(1)
XSTO
Primary
XDUS
XFRA
CBOE
kr
76.
95
+0.35
+0.4569%
kr
33.13B
Market Cap
-
P/E Ratio
0.39%
Div Yield
515,417
Volume
-
Eps
kr
76.6
Previous Close
Watching
Watch
Add Transaction
Day Range
74.35
77.7
Year Range
58.64
131.22
Want to track
ASKER
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Asker Healthcare Group AB (ASKER) Statistics
Valuation metrics
Market Cap
33.13B
Enterprise value
36.35B
Trailing P/E (ttm)
52.65
Forward P/E
23.05
PEG ratio
0.43
Price/Sales (ttm)
1.81
Price/Book (mrq)
4.58
Enterprise Value/Revenue
2.1
Enterprise Value/EBITDA
22.65
Overview
Shares outstanding
383.04M
Float
227.59M
Shares short
-
% Held by insiders
0.02%
% Held by institutions
0.85%
Average volume (10 days)
613.2K
Average volume (90 days)
441.25K
Price summary
52-Week low
58.64
52-Week high
131.22
Beta
-
50-Day moving average
79.16
200-Day moving average
76.61
Dividends and splits
Forward annual dividend rate
0.39
Forward annual dividend yield
0.0049%
Trailing annual dividend rate
0.39
Trailing annual dividend yield
0.0048%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
15 May 2026
Ex-Dividend Date
8 May 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.03%
Operating margin
0.07%
Operational effectiveness
Return on assets
0.03%
Return on equity
0.09%
Income Statement
Revenue (ttm)
17.31B
Revenue per share (ttm)
45.2
Quarterly revenue growth (yoy)
0.13%
Gross profit (ttm)
7.11B
EBITDA
1.35B
Net income to common (ttm)
594M
Diluted EPS (ttm)
1.55
Quarterly earnings growth (yoy)
1.12%
Balance Sheet
Total cash (mrq)
945M
Total cash per share (mrq)
2.47
Total debt (mrq)
6.02B
Total Debt/Equity (mrq)
0.88
Current ratio (mrq)
1.31%
Book value per share (mrq)
17.94
Cash Flow
Cash flow statement
1.64B
Levered free cash flow (LFCF)
990.75M